
Lutetium-177 (Lu-177) Radioligand Therapy Lutetium-177 therapy is a targeted radionuclide treatment in which a radioactive substance linked to a specific molecule binds to cancer cells and delivers radiation directly to them. The treatment is administered intravenously under the supervision of a Nuclear Medicine specialist, with monitoring before and after the procedure to ensure safety and treatment effectiveness. Package Includes: Nuclear Medicine specialist consultation Required laboratory tests and medical evaluation Lutetium-177 treatment administration Radiation safety monitoring Post-treatment medical assessment Follow-up recommendations Treatment Duration: According to the patient's clinical condition and treatment protocol Hospitalization: As required by the nuclear medicine team and radiation safety regulations
1 days in the hospital
Bookimed is an international medical tourism platform founded in 2014. We are made of people and for people — and that’s our core value. We cooperate with simply the best doctors & clinics and work hard every day to make people healthier and happier. Over 800,000 patients used the platform so far. Additionally to our primary activities, we collaborate with charity projects and create supportive communities. Our main office is in Kyiv, Ukraine, still, we’re online 24/7 wherever you are.
The information provided on the website is not a guide to action and should not be construed as medical advice or treatment recommendation, nor should it be considered a substitute for a visit to a doctor.